On Thursday May 1, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced their first-quarter results, revealing an 18% increase in net income to $744 million from $6330 million last year. Teva did report higher quarterly earnings that beat analysts’ estimates by one cent, but analysts also expected a revenue of $5.1 billion, and the company came up short with $5.0 billion. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares after opening at $51.61 moved to $51.61 on last trade day and at the end of the day closed at $49.58. Company price to sales ratio in past twelve months was calculated as 2.32 and price to cash ratio as 52.53. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) showed a positive weekly performance of 0.04%.
Orexigen(R) Therapeutics, Inc. (NASDAQ:OREX), a biopharmaceutical company focused on the treatment of obesity, will announce financial results for the first quarter 2014, on Thursday, May 8, 2014. Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares fell -4.53% in last trading session and ended the day on $5.48. OREX return on equity ratio is recorded as -179.80% and its return on assets is -64.50%. Orexigen Therapeutics, Inc. (NASDAQ:OREX) yearly performance is -10.75%.
Dynavax Technologies Corporation (NASDAQ:DVAX) reported a loss of 5 cents per share in the first quarter of 2014, in line with the Zacks Consensus Estimate. The loss reported in the year-ago quarter was 11 cents per share. Dynavax Technologies Corporation (NASDAQ:DVAX) shares moved down -7.01% in last trading session and was closed at $1.46, while trading in range of $1.45 – $1.59. Dynavax Technologies Corporation (NASDAQ:DVAX) year to date (YTD) performance is -25.51%.
Morgan Stanley upgraded shares of Endo International PLC (NASDAQ:ENDP) from an equal weight rating to an overweight rating in a research report sent to investors on Friday morning, AmericanBankingNews.com reports. The firm currently has $79.00 price target on the stock. Endo International PLC (NASDAQ:ENDP) weekly performance is 5.63%. On last trading day company shares ended up $66.81. Endo International PLC (NASDAQ:ENDP) distance from 50-day simple moving average (SMA50) is -1.51%. Analysts mean target price for the company is $70.89.